Neonatal hepatic drug elimination

Pharmacology and Toxicology

Volumn 88, Issue 1, 2001, Pages 3-15

  Gow, Paul J ^a   Ghabrial, Hany ^a   Smallwood, Richard A ^a   Morgan, Denis J ^b   Ching, Michael S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MIDAZOLAM; MORPHINE; PARACETAMOL; XENOBIOTIC AGENT;

DRUG CLEARANCE; DRUG ELIMINATION; DRUG GLUCURONIDATION; DRUG METABOLISM; ENZYME METABOLISM; LIVER BLOOD FLOW; LIVER CLEARANCE; LIVER PERFUSION; NEWBORN PERIOD; PRIORITY JOURNAL; SHORT SURVEY; SULFATION;

OVIS ARIES;

EID: 0035150714     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2001.088001003.x     Document Type: Short Survey

References (163)

1. Adams, F. H.: Patency of the ductus venosus and disease. Eur. J. Pediat. 1992, 151, 572.
2. Agrawal A. K. & B. H. Shapiro: Imprinted overinduction of hepatic CYP2B1 and 2B2 in adult rats neonatally exposed to phenobarbital. J. Pharmacol. Exp. Therap. 1996, 279, 991-999.
3. Alam, S. N., R. J. Roberts & L. J. Fischer: Age-related differences in salicylamide and acetaminophen conjugation in man. J. Pediat. 1977, 90, 130-135.
4. Apatu, R. S. K. & R. J. Barnes: Blood flow to and the metabolism of glucose and lactate by the liver in vivo in fetal, newborn and adult sheep. J. Physiol. 1991, 436, 431-447.
5. Atlas, S. A., A. R. Boobis, J. S. Felton, S. S. Thorgeirsson & D. W. Nebert: Ontogenetic expression of polycyclic aromatic compound-inducible monooxygenase activities and forms of cytochrome P-450 in rabbit. Evidence for temporal control and organ specificity of two genetic regulatory systems. J. Biol. Chem. 1977, 252, 4712-4721.
6. Autret, E., J. P. Dutertre, M. Breteau, A. P. Jonville, Y. Furet & J. Laugier: Pharmacokinetics of paracetamol in the neonate and infant after administration of propacetamol chlorhydrate. Dev. Pharmacol. Therap. 1993, 20, 129-134.
7. Barbera-Guillem, E., J. M. Arrue, J. Ballesteros & F. Vidal-Vanaclocha: Structural changes in endothelial cells of developing rat liver in the transition from fetal to postnatal life. J. Ultrastruct. Mol. Struct. Res. 1986, 97, 197-206.
8. Barker, E. V., R. Hume, A. Hallas & W. H. Coughtrie: Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology 1994, 134, 982-989.
9. Bock, K. W., A. Forster, H. Gschaidmeier, M. Bruck, P. Munzel, W. Schareck, S. Fournel-Gigleux & B. Burchell: Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem. Pharmacol. 1993, 45, 1809-1814.
10. Borlakoglu, J. T., A. Scott, C. J. Henderson & C. R. Wolf: Expression of P450 isoenzymes during rat liver organogenesis. Int. J. Biochem. 1993, 25, 1659-1668.
11. Bortolotti, A., M. Corada, M. M. Barzago, A. Celardo, A. Guaitani & M. Bonati: Pharmacokinetics of theophylline in the newborn and adult rabbit. In vivo and isolated perfused liver approaches. Drug Metab. Disp. 1991, 19, 430-435.
12. Botti, J. J., D. I. Edelstone, S. N. Caritis & E. Mueller-Heubach: Portal venous blood flow distribution to liver and ductus venosus in newborn lambs. Amer. J. Obstet. Gynecol. 1982, 144, 303-308.
13. Bourgeois, B. F., & W. E. Dodson: Phenytoin elimination in newborns. Neurology 1983, 33, 173-178.
14. Bristow, J., M. A. Rudolph, J. Itskovitz & R. Barnes: Hepatic oxygen and glucose metabolism in the fetal lamb. J. Clin. Invest. 1983, 71, 1047-1061.
15. Burchell, B., M. Coughtrie, M. Jackson, D. Harding, S. Fournel-Gigleux, J. Leakey & R. Hume: Development of human liver UDP-glucuronsyltransferases. Dev. Pharmacol. Therap. 1989, 13, 70-77.
16. Burtin, P., E. Jacqz-Aigrain, P. Girard, R. Lenclen, J. F. Magny, P. Betremieux, C. Tehiry, L. Desplanques & P. Mussat: Population pharmacokinetics of midazolam in neonates. Clin. Pharmacol. Therap. 1994, 56, 615-625.
17. PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 1989, 86, 7696-7700.
18. Cappiello, M., M. Franchi, A. Rane & G. M. Pacifici: Sulphotransferase and its substrate: adenosine-3′-phosphate-5′-phosphosulphate in human fetal liver and placenta. Dev. Pharmacol. Therap. 1990, 14, 62-65.
19. Cazeneuve, C., G. Pons, E. Rey, J.-M. Treluyer, T. Cresteil, G. Thiroux, P. D'athis & G. Olive: Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults. Brit. J. Clin. Pharmacol 1994, 37, 405-412.
20. Chay, P. C. W., B. J. Duffy & J. S. Walker: Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin. Pharmacol. Therap. 1992, 51, 334-342.
21. Chen, L. J., B. Kane, Y. Bujanover & M. M. Thaler: Development and regulation of bile salt sulfotransferase in rat liver. Biochim. Biophys. Acta. 1982, 713, 358-364.
22. Chhabra, S. K., C. Perella & L. M. Anderson: Induction of hepatic and renal P4502E1 of neonatal rats exposed translactationally to ethanol. Food Chem. Toxicol. 1996, 34, 469-476.
23. Choonara, I. A., P. Mckay, R. Hain & A. Rane: Morphine metabolism in children. Brit. J. Clin. Pharmacol. 1989, 28, 599-604.
24. Choonara, I. A., Y. Ekbom, B. Lindstrom & A. Rane: Morphine sulphation in children. Brit. J. Clin. Pharmacol. 1990, 30, 897-900.
25. Ciotti, M., A. Marrone, C. Potter & I. S. Owens: Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 1997, 7, 485-195.
26. Coceani, F.: The control of the ductus venosus: an update. Eur. J. Pediat. 1993, 152, 976-977.
27. Coffman, B. L., G. R. Rios, C. D. King & T. R. Tephly: Human UGT2B7 catalyzes morphine glucuronidation. Drug. Met. Disp. 1997, 25, 1-4.
28. Conroy, S., I. Choonara, P. Impicciatore, A. Mohn, H. Arnell, A. Rane, C. Knoeppel, H. Seyberth, C. Pandolfini, M. P. Raffaelli, F. Rocchi, M. Bonati, G. Jong, M. de Hoog & J. van den Anker: Survey of unlicensed and off label drug use in paediatric wards in European countries. Brit. Med. J. 2000, 320, 79-82.
29. Corada, M., A. Bortolotti, M. M. Barzago, A. Celardo, M. Bonati & A. Guaitani: Pharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis. Drug Metab. Disp. 1992, 20, 826-831.
30. Coughtrie, M. W., B. Burchell, J. E. A. Leakey & R. Hume: The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol. Pharmacol. 1988, 34, 729-735.
31. Craft, A. W., J. T. Brachlebank, E. N. Hey & R. H. Jackson: The "gray toddler": chloramphenicol toxicity. Arch. Dis. Child. 1974, 49, 235-237.
32. Cresteil, T., P. Beaune, C. Celier, J. P. Leroux & F. P. Guengerich: Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. J. Pharmacol. Exp. Therap. 1986, 236, 269-276.
33. Cresteil, T.: Onset of xenobiotic metabolism in children: toxicological implications. Food Addit. Contam. 1998, Suppl. 15, 45-51.
34. de Wildt, S. N., G. L. Kearns, J. S. Leeder & J. N. van den Anker: Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin. Pharmacokin. 1999a, 36, 439-452.
35. de Wildt, S. N., G. L. Kearns, J. S. Leeder & J. N. van den Anker: Cytochrome P450 3A: ontogeny and drug disposition. Clin. Pharmacokin. 1999b, 37, 485-505.
36. Dempsey, D., P. Jacob & N. L. Benowitz: Nicotine metabolism and elimination kinetics in newborns. Clin. Pharmacol. Therap. 2000, 67, 458-465.
37. Dension, M. S., & P. J. Whitlock: Xenobiotic inducible transcription of cytochrome P450 genes. J. Biol. Chem. 1995, 270, 18175-18178.
38. Dundee, J. W., N. J. Halliday, K. W. Harper & R. N. Brogden: Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 1984, 28, 519-543.
39. Dutton, G. J. & J. E. Leakey: The perinatal development of drug-metabolizing enzymes: what factors trigger their onset? Prog. Drug Res. 1981, 25, 189-273.
40. Edelstone, D. I., A. M. Rudolph & M. A. Heymann: Liver and ductus venosus blood flows in fetal lambs in utero. Circ. Res. 1978, 42, 426-433.
41. Edelstone, D. I., & I. R. Holzman: Oxygen consumption by the gastrointestinal tract and liver in conscious newborn lambs. Amer. J. Physiol. 1981, 240, G297-G304.
42. Ekins, S. & S, A. Wrighton: The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 1999, 31, 719-754.
43. Fugelseth, D., R. Lindemann, K. Liestol, T. Kiserud & A. Langslet: Ultrasonographic study of ductus venosus in healthy neonates. Arch. Dis. Child Fetal Neonatal. Ed. 1997, 77, F131-F134.
44. Garrettson, L. K., J. A. Procknal & G. Levy: Fetal acquisition and neonatal elimination of a large amount of salicylate. Clin. Pharmacol. Therap. 1975, 17, 98-103.
45. Gauntlett, I. S., D. M. Fisher, R. E. Hertzka, E. Kuhls, M. J. Spellman & C. Rudolph: Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 1988, 69, 683-687.
46. Gerecke, M.: Chemical structure and properties of midazolam compared with other benzodiazepines. Brit. J. Clin. Pharmacol. 1983, 16, 11S-16S.
47. Gershanik, J., B. Boeder, H. Ensley, S. McCloskey & W. George: The gasping syndrome and benzyl alcohol poisoning. New Engl. J. Med. 1982, 307, 1384-1388.
48. Gilissen, R. A., R. Hume, J. H. Meerman & M. W. Coughtrie: Sulphation of N-hydroxy-4-aminobiphenyl and N-hydroxy-4-acetylaminobiphenyl by human foetal and neonatal sulphotransferase. Biochem. Pharmacol. 1994, 48, 837-840.
49. Gillam, E. M., R. M. Wunsch, Y. F. Ueng, T. Shimada, P. E. Reilly, T. Kamataki & F. P. Guengerich: Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5′ modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 1997, 346, 81-90.
50. Gladtke, E.: Pharmacokinetic studies on phenylbutazone in children. Farmaco. [Sci] 1968, 23, 897-906.
51. Gleason, C. A., C. Roman & A. M. Rudolph: Hepatic oxygen consumption, lactate uptake, and glucose production in neonatal lambs. Pediat. Res. 1985, 19, 1235-1239.
52. Gonzalez, F. J.: Control of constitutively-expressed developmentally-activated rat hepatic cytochrome genes. Keio J. Med. 1992, 41, 68-75.
53. Gonzalez, F. J. & Y. H. Lee: Constitutive expression of hepatic cytochrome P450 genes. FASEB J. 1996, 10, 1112-1117.
54. Gores, G. J., L. J. Kost & N. F. LaRusso: The isolated perfused rat liver: conceptual and practical considerations. Hepatology 1986, 6, 511-517.
55. Gorski, J. C., S. D. Hall, D. R. Jones, M. VandenBranden & S. A. Wrighton: Regioselective biotransformation of midazolam by members of the human cytchrome P450 3A (CYP3A) subfamily. Biochem. Pharmacol. 1994, 47, 1643-1653.
56. Gow, P., S. Treepongkaruna, M. S. Ching, H. Ghabrial, A. Shulkes, R. A. Smallwood, C. J. Jin & D. J. Morgan: The uptake and excretion of sodium taurocholate by the isolated perfused neonatal sheep liver. J. Pharm. Sci. 1999, 88, 445-449.
57. Gow, P., H. Ghabrial, S. Treepongkaruna, A. Shulkes, R. A. Smallwood, D. J. Morgan & M. S. Ching: Conjugation of para-nitrophenol by the isolated perfused neonatal sheep liver. J. Pharm. Sci. 2000a, 89, 36-44.
58. Gow, P., S. Treepongkaruna, H. Ghabrial, A. Shulkes, R. A. Smallwood, D. J. Morgan & M. S. Ching: Neonatal hepatic propranolol elimination: studies in the isolated perfused neonatal sheep liver. J. Pharm. Sci. 2000b, 89, 586-593.
59. Green, M. D., C. D. King, B. Mojarrabi, P. I. Mackenzie & T. R. Tephly: Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab. Dispos. 1998, 26, 507-512.
60. Hakkola, J., R. Pasanen, S. Purkunen, S. Saarikoski, O. Pelkonen, J. Maenpaa, A. Rane & H. Raunio: Expression of xenobiotic metabolising cytochrome P450 forms in human adult and foetal liver. Biochem. Pharmacol. 1994, 48, 59-64.
61. Hakkola, J., E. Tanaka & O. Pelkonen: Developmental expression of cytochrome P450 enzymes in human liver. Pharmacology Toxicology 1998, 82, 209-217.
62. Hansson, T., B. Naslund, A. Blanck & A. Rane: Perinatal opiate exposure. Effects on metabolism of xenobiotics and steroids in adult rat liver. Dev. Pharmacol. Therap. 1989, 12, 146-152.
63. Harrison, F. A., J. L. Linzell & J. Y. F. Paterson: Oxygen consumption by the liver of the conscious sheep. J. Physiol. 1972, 222, 48P-49P.
64. Hartley, R., M. Green, M. Quinn & M. I. Levene: Pharmacokinetics of morphine infusion in neonates. Arch. Dis. Child. 1993, 69, 55-58.
65. Hartwig, S., B. Roth & M. Theisohn: Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur. J. Pediat. 1991, 150, 784-788.
66. Her, C., T. C. Wood, E. E. Eichler, H. W. Mohrenweiser, L. S. Ramagli, M. J. Siciliano & R. M. Weinshilboum: Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. Genomics 1998, 53, 284-295.
67. Hughes, J., A. M. Gill, H. Mulhearn, E. Powell & I. Choonara: Steady-state plasma concentrations of midazolam in critically ill infants and children. Annals Pharmacotherap. 1996, 30, 27-30.
68. Hughes, R. L., R. T. Mathie, W. Fitch & D. Campbell: Liver blood flow and oxygen consumption during metabolic acidosis and alkalosis in the greyhound. Clin. Sci. 1981, 60, 355-361.
69. Jacqz-Aigrain, E., C. Wood & I. Robieux: Pharmacokinetics of midazolam in critically ill neonates. Eur. J. Clin. Pharmacol. 1990, 39, 191-192.
70. Jacqz-Aigrain, E., P. Daoud, B. Burtin, S. Maherzi & F. Beaufils: Pharmacokinetics of midazolam during continuous infusion. Eur. J. Clin. Pharmacol. 1992, 42, 329-332.
71. Janes, J. & P. A. Routledge: Recent developments in the management of paracetamol (acetaminophen) poisoning. Drug Safety 1992, 7, 170-177.
72. Jones, C. T. & T. P. Rolph: Metabolic events associated with the preparation of the fetus for independent life. Ciba Found. Symp. 1981, 86, 214-233.
73. Jones, D. P.: Hypoxia and drug metabolism. Biochem. Pharmacol. 1981, 30, 1019-1023.
74. Kaddouri, M., N. Brasset, M. Alvinerie, C. Eeckhoutte, C. Bonfils, J. Derancourt & P. Galtier: Ontogenic development of liver progesterone metabolism in female sheep. Contribution of cytochrome P4502B and P4503A subfamilies. J. Steroid Biochem. Mol. Biol. 1992, 42, 499-508.
75. Kanamura, S., K. Kanai & J. Watanabe: Fine structure and function of hepatocytes during development. J. Electron Microsc. Tech. 1990, 14, 92-105.
76. Kanai, K., S. Kanamura & J. Watanabe: Peri and postnatal development of heterogeneity in the amounts of endoplasmic reticulum in mouse hepatocytes. Amer. J. Anat. 1986, 175, 471-480.
77. Kawade, N. & S. Onishi: The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem. J. 1981, 196, 257-260.
78. Kawai, M., S. M. Bandiera, T. K. H. Chang, F. M. Poulet, P. M. Vancutsem & G. D. Bellward: Modulation of hepatic CYP2A1, CYP2C11, and CYP3A9 expression in adult rats by neonatal administration of tamoxifen. Drug Metab. Disp. 1999, 27, 1392-1398.
79. Kikkawa, Y., I. Fujita & R. K. Sindhu: Neonatal hyperoxia and cytochrome P450 imprinting in adulthood. Pediat. Res. 1994, 35, 255-258.
80. Kitada, M. & T. Kamataki: Cytochrome P450 in human fetal liver: Significance and fetal specific expression. Drug Metab. Rev. 1994, 26, 305-323.
81. Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa, R. Kato & Y. Kanabuko: Purification and properties of cytochrome P-450 from homogenates of human foetal livers. Arch. Biochem. Biophys. 1985, 241, 275-280.
82. Klaassen, C. D. & J. B. Watkins: Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol. Rev. 1984, 36, 1-67.
83. Kobayashi, T., A. Tatano, H. Yokota, T. Onaga, T. Watanabe & A. Yuasa: Small intestinal UDP-glucuronsyltransferase sheUG-T1A07: partial purification and cDNA cloning from sheep small intestine. Arch. Biochem. Biophys. 1999, 364, 143-152.
84. Kraus, D. M., J. H. Fischer, S. Reitz, S. A. Kecskes, T. F. Yeh, K. M. McCulloch, E. C. Tung & M. J. Cwik: Alterations in theophylline metabolism during the first year of life. Clin. Pharmacol. Therap. 1993, 54, 351-359.
85. Kronbach, T., D. Mathys, M. Umenco, F. J. Gonzalez & U. A. Meyer: Oxidation of midazolam and trizolam by human cytochrome P450IIIA4. Mol. Pharmacol. 1989, 36, 89-96.
86. Kuhnert, B. R., T. L. Gross, P. M. Kuhnert, P. Erhard & W. T. Brashar: Ritodrine pharmacokinetics. Clin. Pharmacol. Therap. 1986, 40, 656-664.
87. Lacroix, D., M. Sonnier, A. Moncion, G. Cheron & T. Cresteil: Expression of CYP3A in the human liver. Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur. J. Biochem. 1997, 247, 625-634.
88. Lautt, W. W: Effect of stimulation of hepatic nerves on hepatic oxygen uptake and blood flow. Am. J. Physiol. 1977, 232, H652-H656.
89. Leakey, J. E. A., Z. R. Althaus, J. R. Bailey & W. Slikker Jr.: UDP-glucuronyltransferase activity exhibits two developmental groups in liver from foetal rhesus monkeys. Biochem. J. 1983, 214, 1007-1009.
90. Leakey, J. E. A.: Influence of glucocorticoids and polycyclic aromatic hydrocarbons on hepatic drug-metabolizing enzyme development during the perinatal period. Biochem. Soc. Trans. 1984, 12, 44-45.
91. Leakey, J. E. A., Z. R. Althaus, J. R. Bailey & W. Slikker Jr.: Dexamethasone induces hepatic cytochrome P-450 content and increases certain monooexygenase activities in rhesus monkey fetuses. Biochem. Pharmacol. 1986, 35, 1389-1391.
92. Leakey, J. E. A., R. Hume & B. Burchell: Development of multiple activities of UDP-glucuronyltransferase in human liver. Biochem. J. 1987, 243, 859-861.
93. Lee, T. C., B. Charles, P. Steer, V. Flenady & A. Shearman: Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Clin. Pharmacol. Therap. 1997, 61, 628-640.
94. Levy, G., N. N. Khanna, D. M. Soda, O. Tsuzuki & L. Stern: Pharmacokinetics of acetaminophen in the human neonate: Formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics 1975, 55, 818-825.
95. Linzell, J. L., B. P. Setchell & D. B. Lindsay: The isolated perfused liver of the sheep: an assessment of its metabolic, synthetic and excretory functions. Q. J. Physiol. Cogn. Med. Sci. 1971, 56, 53-71.
96. Loberant, N., M. Barak, D. Gaitini, M. Herskovits, M. Ben-Elisha & N. Roguin: Closure of the ductus venosus in neonates: findings on real-time gray-scale, color-flow doppler, and duplex doppler sonography. Amer. J. Roentgenol. 1992, 159, 1083-1085.
97. Liu, L., & C. D. Klaassen: Ontogeny and hormonal basis of male-dominant rat hepatic sulfotransferases. Mol. Pharmacol. 1996, 50, 565-572.
98. Lynn, A. M., K. E. Opeim & D. C. Tyler: Morphine infusion after pediatric surgery. Crit. Care Med. 1984, 12, 863-866.
99. Lynn, A. M., & J. T. Slattery: Morphine pharmacokinetics in early infancy. Anesthesiology 1987, 66, 136-139.
100. Mackenzie, P. I., I. S. Owens, B. Burchell, K. W. Bock, A. Bairoch, A. Belanger, S. Fournel-Gigleux, M. Green, D. W. Hum, T. Iyanagi, D. Lancet, P. Louisot, J. Magdalou, J. R. Chowdhury, J. K. Ritter, H. Schachter, T. R. Tephly, K. F. Tipton & D.W. Nebert: The UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997, 7, 255-269.
101. Macsween, R. N. M. & R. J. Scothorne: Developmental anatomy and normal structure. In: Pathology of the liver. Eds.: R. N. M. Macsween. Churchill Livingstone, 1994, 1-50.
102. Marie, S., F. Roussel & T. Cresteil: Age- and tissue-dependent expression of CYP2C23 in the rat. Biochim. Biophys. Acta 1993, 1172, 124-130.
103. Mathews, H. M. L., I. W. Carson, S. M. Lyons, I. A. Orr, P. S. Collier, P. J. Howard & J. W. Dundee: A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery. Brit. J. Anaesth. 1988, 61, 302-307.
104. McRorie, T. I., A. M. Lynn, M. K. Nespeca, K. E. Opheim & J. T. Slattery: The maturation of morphine clearance and metabolism. Amer. J. Dis. Child 1992, 146, 972-976.
105. Meech, R. & P. I. Mackenzie: Structure and function of uridine diphosphate glucuronosyltransferases. Clin. Exp. Pharmacol. Physiol. 1997, 24, 907-915.
106. Mihaly, G. W., D. J. Morgan, R. A. Smallwood & K. J. Hardy: The developing liver: The steady-state disposition of propranolol in pregnant sheep. Hepatology 1982, 3, 344-349.
107. Mikkelsen, S., V. L. Feilberg, C. B. Christensen & K. E. Lundström: Morphine pharmacokinetics in premature and mature newborn infants. Acta Paediat. 1994, 83, 1025-1028.
108. Miller, R. P., R. J. Roberts & L. J. Fischer: Acetaminophen elimination kinetics in neonates, children and adults. Clin. Pharmacol. Therap. 1976, 19, 284-294.
109. Moreland, T. A., J. E. Brice, C. H. Walker & A. C. Parija: Naloxone pharmacokinetics in the newborn Brit. J. Clin. Pharmacol. 1980, 9, 609-612.
110. Morgan, J. D. & W. S. Hartort: Juvenile liver: age at which one cell thick plates predominate in the human liver. Arch. Pathol. 1961, 71, 86-88.
111. Morselli, P. L., N. Principi, G. J. Tognoni, E. Reali, G. Belvedere, S. M. Standen, F. Sereni: Diazepam elimination in premature and full term infants, and children. Perinat. Med. 1973, 1, 133-141.
112. Mulhall, A., J. De Louvois & R. Hurley: The pharmacokinetics of chloramphenicol in the neonate and young infant. J. Antimicrob. Chemother. 1983, 12, 629-639.
113. Neubert, D.: Significance of pharmacokinetic variables in reproductive and developmental toxicity. Xenobiotica 1988, 18 Suppl 1, 45-58.
114. Nitowsky, H. M., L. Matz & J. A. Berzofsky: Studies on oxidative drug metabolism in the full-term newborn infant. J. Pediatr. 1966, 69, 1139-1149.
115. Onishi, S., N. Kawade & S. Itoh: Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem. J. 1979, 184, 705-707.
116. Pacifici, G. M., M. Franchi, L. Giuliani & A. Rane: Development of glucuronyltransferase and sulphotransferase toward 2-naphthol in human fetus. Dev. Pharmacol. Therap. 1989, 14, 108-114.
117. 1 in the fetal lamb. Amer. J. Obstet. Gynecol. 1990, 163, 1357-1363.
118. Payne, K., F. J. Mattheyse, D. Liedenberg & T. Dawes: The pharmacokinetics of midazolam in paediatric patients. Eur. J. Clin. Pharmacol. 1989, 37, 267-272.
119. Pelkonen, O., P. Arvela & N. T. Karki: 3,4-Benzpyrene and N-methylaniline metabolizing enzymes in the immature human foetus and placenta. Acta. pharmacol. et toxicol. 1971, 30, 385-395.
120. Pelkonen, O., A. Rautio, H. Raunio & M. Pasanen: CYP2A6: a human coumarin 7-hydroxylase. Toxicology 2000, 144, 139-147.
121. Pokela, M. L., K. T. Olkkola, T. Seppälä & M. Koivisto: Age-related morphine kinetics in infants. Dev. Pharmacol. Therap. 1993, 20, 26-34.
122. Radominska-Pandya, A., P. J. Czernik, J. M. Little, E. Battaglia & P. I. Mackenzie: Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab. Rev. 1999, 31, 817-899.
123. Raftogianis, R. B., T. C. Wood, D. M. Otterness, J. A. Van Loon & R. M. Weinshilboum: Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem. Biophys. Res. Common. 1997, 239, 298-304.
124. Ratanasavanh, D., P. Beaune, F. Morel, J. P. Flinois, F. P. Guengerich & A. Guillouzo: Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 1991, 13, 1142-1151.
125. Rich, K J. & A. R. Boobis: Expression and inducibility of P450 enzymes during liver ontogeny. Microsc. Res. Tech. 1997, 39, 424-435.
126. 14C] sodium taurocholate by the isolated perfused fetal sheep liver. Biochem. Pharmacol. 1994, 48, 667-674.
127. Ring, J. A., H. Ghabria, M. S. Ching, A. Shulkes, R. A. Smallwood & D. J. Morgan: Fetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver. Drug Metab. Disp. 1995, 23, 190-196.
128. Ring, J A., H. Ghabrial, M. S. Ching, A. Shulkes, R. A. Smallwood & D. J. Morgan: Conjugation of para-nitrophenol by the isolated perfused fetal sheep liver. Drug Metab. Disp. 1996, 24, 1378-1384.
129. Rollins, D. E., H. Glaumann & A. Rane: Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science 1979, 205, 1414-1416.
130. Rosen, D. A. & K. R. Rosen: Midazolam for sedation in the paediatric intensive care unit. Intensive Care Med. 1991, 17, S15-S19.
131. Rudolph, A. M.: Hepatic and ductus venosus blood flows during fetal life. Hepatology 1983, 3, 163-174.
132. Scragg, I., M. Pollard & B. Burchell: The temporary postnatal decline in glucuronidation of certain phenols by rat liver. Biochem. J. 1983, 241, 533-537.
133. Scragg, I., C. Celier & B. Burchell: Congenital jaundice in rats due to the absence of hepatic bilirubin UDP-glucuronyltransferase enzyme protein. FEBS Lett. 1985, 183, 37-42.
134. Shaw, P. M., M. C. Weiss & M. Adesnik: Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells. Mol. Pharmacol. 1994, 46, 79-87.
135. Shimada, T., J. Watanabe, K. Kawajiri, T. R. Sutter, F. P. Guengerich, E. M. J. Gillam, K. Inoue: Catalytic properties of polymorphic human cytochrome P4501B1 variants. Carcinogenesis 1999, 20, 1607-1613.
136. Shimada, T., H. Yamazaki, M. Mimura, Inui, Y. & F. P. Guengerich: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Therap. 1994, 270, 414-423.
137. Shimada, T., H. Yamazaki, M. Mimura, N. Wakamiya, Y. F. Ueng, F. P. Guengerich & Y. Inui: Characterisation of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human foetal livers and adult lungs. Drug Metab. Disp. 1996, 24, 515-522.
138. Shiojiri, N.: Development and differentiation of bile ducts in the mammalian liver. Microsc. Res. Tech. 1997, 39, 328-335.
139. Smallwood, R. H., D. J. Morgan, G. W. Mihaly, D. B. Jones & R. A. Smallwood: Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion methods. J. Pharmacokin. Biopharm. 1988, 16, 377-396.
140. Sonnier, M., & T. Cresteil: Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem. 1998, 251, 893-898.
141. Steiner, E., C. Von Bahr & A. Rane: Sulphate and glucuronic acid conjugation of harmol in human fetal and adult liver tissue. Dev. Pharmacol. Therap. 1982, 5, 14-20.
142. Thummel, K. E., D. M. B. O'Shea, M. F. Paine, D. D. Shen, K. L. Kunze, J. D. Perkins & G. R. Wilkinson: Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A4-mediated metabolism. Clin. Pharmacol. Therap. 1996, 59, 491-502.
143. Thummel, K. E. & G. R. Wilkinson: In vitro and in vivo drug interactions involving human CYP3A4. Ann. Rev. Pharmacol. Toxicol. 1998, 38, 389-430.
144. Tomson, G., N. O. Lunell, A. Sundwall & A. Rane: Placental passage of oxazepam and its metabolism in the mother and newborn. Clin. Pharmacol. Therap. 1979, 25, 74-81.
145. Townsend, S. F., C. D. Rudolph & A. M. Rudolph: Changes in ovine hepatic circulation and oxygen consumption at birth. Pedat. Res. 1989, 25, 300-304.
146. Treluyer J. M., E. J. Jacqz-Aigrain, F. Alvarez & T. Cresteil: Expression of CYP2D6 in developing human liver. Eur. J. Biochem. 1991, 202, 583-588.
147. Treluyer, J. M., G. Cheron, M. Sonnier & T. Cresteil: Cytochrome P-450 expression in sudden infant death syndrome. Biochem. Pharmacol. 1996, 52, 497-504.
148. Treluyer, J. M., G. Gueret, G. Cheron, M. Sonnier & T. Creisteil: Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivolin-vitro correlation and inducibility. Pharmacogenetics 1997, 7, 441-452.
149. Vauzelle-Kervroedan, F., E. Rey, A. Pariente-Khayat, T. Bienvenu, J. Badoual, G. Olive & G. Pons: Non invasive in vivo study of the maturation of CYP IIIA in neonates and infants. Eur. J. Clin. Pharmacol. 1996, 51, 69-72.
150. Vieira, I., M. Sonnier & T. Cresteil: Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 1996, 238, 476-483.
151. Villeneuve, J. P., P. M. Huet, L. Gariepy, D. Fenyves, B. Willems, J. Cote, R. Lapointe & D. Marleau: Isolated perfused cirrhotic human liver obtained from liver transplant patients: a feasibility study. Hepatology 1990, 12, 257-263.
152. Wang, L. H., A. M. Rudolph & L. Z. Benet: Comparative study of acetaminophen disposition in sheep at three developmental stages: the fetal, neonatal and adult periods. Dev. Pharmacol. Therap. 1990, 14, 161-179.
153. Wang, R. W., D. J. Newton, N. Y. Liu, M. Shou, T. Rushmore & A. Y. Lu: Inhibitory anti-CYP3A4 peptide antibody: mapping of inhibitory epitope and specificity toward other CYP3A isoforms. Drug Metab. Disp. 1999, 27, 167-172.
154. Weinshilboum, R. M., D. M. Otterness, I. A. Aksoy, T. C. Wood, C. Her & R. B. Raftogianis: Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. FASEB J. 1997, 11, 3-14.
155. Weiss, C. F., A. J. Glazko & J. K. Weston: Chloramphenicol in the newborn infant. A physiological explanation of its toxicity when given in excessive doses. New Engl. J. Med. 1960, 262, 787-794.
156. Widdowson, E. M. & D. E. Crabb: Changes in the organs of pigs in response to feeding for the first 24 hours after birth. I. The internal organs and muscles. Biol. Neonate 1976, 28, 261-271.
157. Wishart, G. J. & G. J. Dutton: Regulation of onset of development of UDP-glucuronosyltransferase activity towards o-aminophenol by glucocorticoids in late-foetal rat liver in utero. Biochem. J. 1977, 168, 507-511.
158. Wishart, G. J.: Functional heterogeneity of UDP-glucuronosyltransferase as indicated by its differential development and inducibility by glucocorticoids. Demonstration of two groups within the enzyme's activity towards twelve substrates. Biochem. J. 1978, 174, 485-489.
159. Wu, D. & A. I. Cederbaum: Induction of liver cytochrome P4502E1 by pyrazole and 4-methylpyrazole in neonatal rats. J. Pharmacol. Exp. Therap. 1993, 264, 1468-1473.
160. Wynne, H. A., L. H. Cope, E. Mutch, M. D. Rawlins, K. W. Woodhouse & O. F. James: The effect of age upon liver blood volume and apparent liver blood flow in healthy man. Hepatology 1989, 9, 297-301.
161. Yaffe, S. J., A. Rane, F. Sjöqvist, L. O. Boréus & S. Orrenius: The presence of a monooxygenase system in human fetal liver microsomes. Life Sci. 1970, 9, 1189-1200.
162. Ziegler, W. H., E. Schalch, B. Leishman & M. Eckert: Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxymetabolites. Brit. J. Clin. Pharmacol. 1983, 16, 63S-69S.
163. Zink, J & G. R. V. Van Petten: Time course of closure of the ductus venosus in the newborn lamb. Pediat. Res. 1980, 14, 1-3.